Sarino, Eldie .
HRN: 12-30-23 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/14/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/14/2024
01/20/2024
IV
300mg
Q8
Bacterial Skin Infection
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes